Abstract
Abstract
The effects of third ventricular (3V) injection of the β-adrenergic antagonist, propranolol (PROPR), a selective β1-antagonist, metoprolol (MET), a selective β2-antagonist, IPS 339, and a β-adrenergic agonist (–) isoproterenol (ISOPR), on plasma concentrations of luteinizing hormone (LH), follicle stimulating hormone (FSH), and growth hormone (GH) were studied in conscious, ovariectomized (OVX) rats. Samples were removed from unrestrained rats which had been previously implanted with atrial and 3V cannulae, and plasma hormone levels were determined by radioimmunoassay (RIA). Intraventricular injection of PROPR (30 μg), MET (40 μg), or IPS 339 (20 μg) induced a gradual elevation in plasma GH concentrations, whereas ISOPR (30 μg) reduced plasma GH. ISOPR (30 μg) brought about a decrease in plasma LH concentrations, but PROPR, MET and IPS 339 had no effect on LH levels. PROPR (30 μg) increased plasma FSH concentrations, but there was no significant effect of MET, IPS 339 or ISOPR on FSH secretion. The results indicate that the β-adrenergic system can inhibit the release of GH, LH, and FSH. This system appears to have a tonic inhibitory effect on GH and FSH but not LH release in the OVX rat.
Get full access to this article
View all access options for this article.